Institutional investors purchased a net $4.4 million shares of NBIX during the quarter ended March 2016 and now own 102.78% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SECTORAL ASSET MANAGEMENT, INC. Bought 1.2 Million shares of Neurocrine Biosciences In...
INVESCO POWERSHARES CAPITAL MANA... Bought 758.8 Thousand shares of Neurocrine Biosciences In...